Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bioweapon ricin - scientists solve mystery through revolutionary new technology

02.12.2011
A key protein that controls how the deadly plant poison and bioweapon ricin kills, has finally been identified by researchers at the Institute of Molecular Biotechnology in Vienna, Austria. The discovery was made using a revolutionary technology that combines stem cell biology and modern screening methods, and reported today (Friday 2 December 2011) in the scientific journal Cell Stem Cell.

Shocking news spread in August this year. Al Quaida, a terror organization, was reported to be producing bombs containing the poison ricin to attack shopping centers, airports, or train stations. Since the First World War, ricin has had a gruesome reputation as a bioweapon. It is one of the deadliest plant based poisons in the world. Even a tiny amount can kill a person within two to three days after getting into the bloodstream. And it comes from the humble castor oil bean, available in many health food shops or online.

How the poison works

Castor oil is a powerful laxative, used medicinally for centuries, but the raw beans also contain small amounts of the poison ricin. So far no antidote is available. But now Ulrich Elling, a scientist on the research team led by Prof Josef Penninger at the Institute for Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna, has identified a protein molecule called Gpr107. This protein in the targeted cells is essential for the deadly effect of ricin. In other words, cells which lack Gpr107 are immune to the poison.

Ulrich Elling is optimistic, saying "Our research suggests that a specific antidote could now be developed by making a small molecule to block the Gpr107 protein."

New technology allows screening of the entire mammal genome

The researchers at IMBA were able to find in just a few weeks what others have been trying to find for decades. Their rapid success was made possible by a pioneering new method of genetic research developed largely by Ulrich Elling and Josef Penninger. With this new method, an entire mammal genome can be screened for mutations within a reasonable time frame.

Until now, screening methods for mice, rats and other mammals have focused on finding one single mutation. This was done using a technique called RNA interference or by breeding a suitable ‘knock-out mouse’ to study the effect of removing a single gene. But RNA interference doesn't always work, and breeding a knock-out mouse takes years and considerable effort.

That's why Josef Penninger sees this powerful technology as a revolution in biomedicine. "We've now succeeded in combining the genetics of yeast, which has a single chromosome set that allows instant gene mutation, with stem cell biology”, he says. “For decades researchers have been looking for a system in mammals which would allow scientists to reconstruct millions of gene mutations simultaneously. We have solved the puzzle and even broke a paradigm in biology – we managed to make stable mouse stem cells with a single set of chromosomes and developed novel tools to use such stem cells to rapidly check virtually all genes at the same time for a specific function.”

This new technology helped Ulrich Elling in unraveling the toxic effect of ricin. He tested the poison in thousands of different mutations of mouse stem cells, and discovered that 49 different genetic mutations were present in one single protein, Gpr107. Obviously, a mutation in this protein saved the cells.

Combination with stem cell research reveals broad range of applications

The incredible potential in this discovery becomes even clearer in the light of stem cells' ability to transform into any cell in the human body. Josef Penninger is excited. "The possible uses of this discovery are endless. They range from fundamental issues, like which genes are necessary for the proper function of a heart muscle cell, to concrete applications as we have done in the case of ricin toxicity."

Penninger's team is already working on its next projects, including studies on how tumor cells acquire resistance to chemotherapy, a key issue in the development of cancer, and how nerve cells can regenerate, to offer hope in cases of paraplegia.

Notes to news editors:

The scientific study "Forward and Reverse Genetics through Derivation of Haploid Mouse Embryonic Stem Cells" appears in Cell Stem Cell on Friday 2 December 2011.

The study was conducted by an international consortium from Austria, Canada, Germany and the USA under the leadership of IMBA. Special thanks go to William Stanford from the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute, Harald von Melchner and Frank Schnütgen from the University of Cologne, Joseph Ecker from San Diego, and Johannes Zuber and Alex Stark from the IMP in Vienna.

The Institute for Molecular Biotechnology (IMBA) is a research institute of the Austrian Academy of Sciences (Österreichische Akademie der Wissenschaften).

Screening: Systematic examination for defined criteria.

RNA interference: A mechanism in cells through which genes can be switched off.

Knock-out mouse: A mouse in which one or more genes have been deactivated. This genetic alteration is often apparent in the mouse's behavior or appearance. These mice are helpful as models for studying human diseases.

Contact and interview requests:

Evelyn Devuyst, Communications IMBA - Institute of Molecular Biotechnology
Tel. +43 1 797 30 - 3626
evelyn.devuyst@imba.oeaw.ac.at

Evelyn Devuyst | idw
Further information:
http://www.imba.oeaw.ac.at

More articles from Life Sciences:

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

Decoding cement's shape promises greener concrete

08.12.2016 | Materials Sciences

Will Earth still exist 5 billion years from now?

08.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>